JPRN-C000000452
Not yet recruiting
Phase 4
Remission Induction of Very Early Rheumatoid Arthritis with Methotrexate and Etanercept - RIVERAME
Johoku Biological Summit0 sites50 target enrollmentAugust 1, 2006
Conditionsrheumatoid arthritis
Overview
- Phase
- Phase 4
- Intervention
- Not specified
- Conditions
- rheumatoid arthritis
- Sponsor
- Johoku Biological Summit
- Enrollment
- 50
- Status
- Not yet recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •patients who are contra indicated for methotrexate or etanercept
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Phase 1
Remission Induction in Very Early Rheumatoid Arthritis (RIVERA):a comparison of etanercept plus methotrexate plus steroid with standard therapy - RIVERAEUCTR2006-001428-38-GBniversity Hospitals Birmingham NHS Foundation Trust20
Completed
Not Applicable
Remission Induction in Very Early Rheumatoid Arthritis: a comparison of etanercept plus methotrexate plus steroid with standard therapyISRCTN49682259Record Provided by the NHSTCT Register - 2007 Update - Department of Health20
Active, not recruiting
Phase 1
REMission INDuction in very early Rheumatoid ArthritisEUCTR2015-004858-17-NLniversity Medical Center Utrecht (UMCU)267
Completed
Phase 4
REMission INDuction in very early Rheumatoid ArthritisArthritisRA10013361NL-OMON47431niversitair Medisch Centrum Utrecht267
Completed
Not Applicable
Remission induction in early rheumatoid arthritis.Observational study.NL-OMON20139/A200